Mikhail Blagosklonny’s Employment and Education
Mikhail Blagosklonny is an oncology professor, a scientist specializing in aging and cancer, and an editor-in-chief of Cell Cycle and Oncotarget. He is also the editor-in-chief of Aging. He is on the editorial board for Cell Death and Differentiation on Impact Journals, and he is the Cancer Biology & Therapy’s associate editor. He has published more than 270 papers in professional journals. With his work and talents, he has been recognized as one of the most passionate advocates for Rapamycin in longevity research. Also, he is an oncology professor at the Roswell Park Cancer Institute in New York in which he joined in 2009.
Blagosklonny earned his Ph.D. degree in Experimental Medicine and Cardiology and his Master’s degree in Internal Medicine at the First Pavlov State Medical University of St. Petersburg.
His Previous Roles
Before this position, he worked for Ordway Research Institute in Albany, New York as a senior scientist until his current position in 2009. In 2002, he was an associate professor of medicine for the New York Medical College in Valhalla, New York.
His Life’s Work and Passion
He believes that it’s greatly possible to possess a community free from cancer and aging effects. And because of this belief and his passion, he is committed to oncology research. His research consists of a variety of niches, including molecular and cellular biology, cell cycle, tumor suppressors, ontogenesis, clinical investigations, and anti-cancer therapeutics. And as result, he has tons of publications in various, prestigious journals. He is a perfect example of how one can use his career for significant change for humanity concerning dreadful and harmful issues. And he continues his goal for people to live free from cancer and the aging effects which has given him much global recognition. View Mikhail’s profile in LinkedIn